China said it will take “resolute measures” to defend its trading rights, but gave no details on how it will respond to U.S.

Find insight on Sartorius, China’s healthcare industry and more in the latest Market Talks covering health care.

The Swiss drugmaker, which holds European rights to Elevidys, suspended three trials while researchers investigate the death ...

“These findings reaffirm that the current Ocrevus IV 600 mg is optimally dosed to significantly slow disability progression,” ...

Roche Holding AG said a high-dose version of Ocrevus, its best-selling multiple sclerosis drug, failed to outperform the ...

Discover March 2025’s top biotech deals, featuring major collaborations in small molecules, bispecific antibodies and protein ...

Viking Therapeutics VKTX announced that it has completed enrolling study participants in the phase II VENTURE-Oral Dosing study, which is evaluating the safety and efficacy of the oral formulation of ...

For the presentation, please visit Scientific publications - Pipeline - Zealand Pharma. In March 2025, Zealand Pharma and Roche entered a collaboration and license agreement to co-develop and ...

Zealand Pharma has concluded enrolment for its global ... In a recent development, the company has entered a partnership and licence agreement with Roche to jointly develop and commercialise the ...

And Big Pharmas are making bigger moves now too. Last week, Roche announced a deal with Zealand Pharma, a Danish biotech with four obesity peptides in development including a differentiated ...